Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma

Sorafenib demonstrated a survival benefit in the treatment of advanced hepatocellular carcinoma (HCC) in phase III trials. However, almost all the patients included in those trials exhibited well-preserved liver function (Child-Pugh A). The aim of this study was to describe our experience with soraf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Clin Oncol
Autori principali: DA FONSECA, LEONARDO GOMES, BARROSO-SOUSA, ROMUALDO, BENTO, AFONSO DA SILVA ALVES, BLANCO, BRUNA PACCOLA, VALENTE, GABRIEL LUIS, PFIFFER, TULIO EDUARDO FLESCH, HOFF, PAULO MARCELO, SABBAGA, JORGE
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4487071/
https://ncbi.nlm.nih.gov/pubmed/26171182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.536
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi